fetal mesenchymal stem cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT03123458)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fetal mesenchymal stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06270199 | Phase 2 | Jan 11, 2024 | Universidad Complutense de Madrid |
| NCT03123458 | Phase 1 | Jan 1, 2016 | Shenzhen Geno-Immune Medical Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Universidad Complutense de Madrid | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1